A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly ...
Absci Corporation (NASDAQ:ABSI) is one of the best biotech penny stocks to buy according to analysts. On December 11, Absci ...
1hon MSN
BTIG Initiates Invivyd (IVVD) Coverage, Cites VYD2311’s Superior Market Potential Over Pemgarda
Additionally, on December 23, Invivyd announced two major regulatory and clinical milestones for VYD2311, which is its ...
And for patients facing extreme limitations to mobility, or who live vast distances from hospitals and clinics, mobile ...
Climb Bio Inc. (NASDAQ:CLYM) is one of the best biotech penny stocks to buy according to analysts. On December 18, H.C.
Clinical Trials Arena on MSN
Mabwell doses first patient in phase II anti-IL-11 antibody trial
The first patient received dosing at Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine.
Northwestern scientists said they found pancreatic cancer cells play a trick on a person's immune system by wearing a sugar ...
TipRanks on MSN
Bluejay Diagnostics scales IL-6 antibody production capacity
An update from Bluejay Diagnostics ( ($BJDX) ) is now available. On December 29, 2025, Bluejay Diagnostics announced it had completed ...
Exploring clinical development plan options including a controlled human infection model (CHIM) and a Phase 2/3 adaptive ...
4don MSN
UT researchers develop antibody modification technique that could change how viruses are treated
Researchers at Texas Biologics at The University of Texas at Austin recently made a discovery that they believe could ...
A multicenter study led by UC Davis Health has tested a new treatment designed to improve care for people with a rare liver ...
Genmab will stop development of its experimental antibody therapy to treat cancer that was in late-stage trials, the Danish ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback